Japanese Markets for Orthopedic Biomaterials 2008

Published by: Millennium Research Group

Published: Apr. 25, 2008

Table of Contents

EXECUTIVE SUMMARY

METHODOLOGY

1.0 ORTHOPEDIC BIOMATERIALS BACKGROUND

1.1 Arthritis and Hyaluronic Acid Viscosupplementation Overview

1.1.1 Osteoarthritis

1.1.2 Rheumatoid Arthritis

1.1.3 Hyaluronic Acid Viscosupplementation

1.2 Bone Graft Overview

1.2.1 Autograft

1.2.2 NP Allograft

1.2.3 Demineralized Bone Matrix

1.2.4 Synthetics

1.2.5 Growth Factors

1.2.6 Orthopedic Stem Cell Products

1.2.7 BGS Applications

2.0 JAPANESE ORTHOPEDIC BIOMATERIAL MARKET

2.1 Market Overview

2.2 Country Overview

2.2.1 Demographics

2.2.2 Reimbursement Issues

2.2.3 Pharmaceutical Affairs Law

2.3 Market Analysis

2.3.1 Market Forecast

2.4 Competitive Analysis

3.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

3.1 Market Overview

3.2 Market Analysis

3.2.1 Procedures

3.2.2 Market Forecast

3.2.3 Market Drivers, Limiters, and Trends

3.2.3.1 Market Drivers

3.2.3.2 Market Limiters

3.2.3.3 Market Trends

3.3 Competitive Analysis

4.0 BONE GRAFT SUBSTITUTE MARKET

4.1 Market Overview

4.2 Market Analysis

4.2.1 Procedures

4.2.1.1 By Material

4.2.1.2 By Application

4.2.2 Market Forecast

4.2.3 Market Drivers and Limiters

4.2.3.1 Market Drivers

4.2.3.2 Market Limiters

4.3 Competitive Analysis

APPENDIX: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

Exhibit 1: Orthopedic Biomaterial Market, Japan (US$), 2006-2012

Exhibit 2: HA Viscosupplementation Treatments, Japan, 2006-2012

Exhibit 3: BGS Market, by Application, Japan (US$), 2006-2012

Exhibit 4: Leading Competitors in the Orthopedic Biomaterial Market, Japan, 2007 _ VIII

METHODOLOGY

Exhibit 5: Currency Exchange Rates, 2007

CHAPTER 1: ORTHOPEDIC BIOMATERIALS BACKGROUND

Exhibit 6: Select HA Viscosupplementation Companies and Products, Japan, 2007

Exhibit 7: Characteristics of Bone Graft Materials

Exhibit 8: Advantages and Disadvantages of Various Bone Graft Materials

Exhibit 9: Selected Synthetic BGS

CHAPTER 2: JAPANESE ORTHOPEDIC BIOMATERIAL MARKET

Exhibit 10: Orthopedic Biomaterial Market, Japan (US$), 2006-2012

Exhibit 11: Over-65 Cohort, as a % of Total Population, Japan, Europe, and US, 2005-2050

Exhibit 12: New Categorization of Medical Devices

Exhibit 13: Orthopedic Biomaterial Market, by Segment, Japan (US$), 2006-2012

Exhibit 14: Orthopedic Biomaterial Market, by Segment, Japan (¥), 2006-2012

Exhibit 15: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Japan, 2007

Exhibit 16: Leading Competitors in the Orthopedic Biomaterial Market, by Segment, as a % of Total, Japan, 2007

CHAPTER 3: HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

Exhibit 17: HA Viscosupplementation Treatments, Japan, 2006-2012

Exhibit 18: HA Viscosupplementation Treatments and Injections, Japan, 2006- 2012

Exhibit 19: HA Viscosupplementation Market, Japan (US$), 2006-2012

Exhibit 20: HA Viscosupplementation Market, Japan (¥), 2006-2012

Exhibit 21: HA Viscosupplementation Market, by Type, Japan (US$), 2007

Exhibit 22: HA Viscosupplementation Market, by Type, Japan (US$ and ¥), 2007

Exhibit 23: Drivers, Limiters, and Trends of the HA Viscosupplementation Market, Japan

Exhibit 24: Leading Competitors in the HA Viscosupplementation Market, by Segment, as a % of Total, Japan, 2007

CHAPTER 4: BONE GRAFT SUBSTITUTE MARKET

Exhibit 25: BGS Market, by Application, Japan (US$), 2006-2012

Exhibit 26: Bone Graft Procedures, by Material, Japan, 2006-2012

Exhibit 27: Synthetic BGS Procedures, by Application, Japan, 2006-2012

Exhibit 28: Average Amount of Synthetic BGS Material Used, by Application, Japan, 2007

Exhibit 29: BGS Market, by Application, Japan (US$), 2006-2012

Exhibit 30: BGS Market, by Application, Japan (¥), 2006-2012

Exhibit 31: Joint Revision and Reconstruction BGS Market, Japan (US$), 2006-2012

Exhibit 32: Joint Revision and Reconstruction BGS Market, Japan (¥), 2006-2012

Exhibit 33: Trauma Surgery BGS Market, Japan (US$), 2006-2012

Exhibit 34: Trauma Surgery BGS Market, Japan (¥), 2006-2012

Exhibit 35: Spinal Fusion BGS Market, Japan (US$), 2006-2012

Exhibit 36: Spinal Fusion BGS Market, Japan (¥), 2006-2012

Exhibit 37: CMF Surgery BGS Market, Japan (US$), 2006-2012

Exhibit 38: CMF Surgery BGS Market, Japan (¥), 2006-2012

Exhibit 39: Drivers and Limiters of the BGS Market, Japan

Exhibit 40: Leading Competitors in the BGS Market, as a % of Total, Japan, 2007

Abstract

The Japanese orthopedic biomaterial market, generated over $400 million in 2007.

This market is comprised of hyaluronic acid, viscosupplementation and bone graft substitutes.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.